Atrium Therapeutics, Inc.
For the period ended Jun 30, 2026. Filed Aug 13, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 13, 2026
RNA$8.34+0.2%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Balance Sheets
(in thousands, except par value)
| June 30, | December 31, | |
|---|---|---|
| 2026 | 2025 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $72,334 | $— |
| Short-term investments | 191,566 | — |
| Prepaid assets | 4,506 | 1,535 |
| Restricted cash, current portion | 311 | — |
| Other current assets | 6,334 | 1,310 |
| Total current assets | 275,051 | 2,845 |
| Restricted cash, net of current portion | 106 | — |
| Property and equipment, net | 4,066 | 2,724 |
| Right-of-use asset | 1,289 | 2,784 |
| Total assets | $280,512 | $8,353 |
| Liabilities and Stockholders’ Equity / Former Parent’s Deficit | ||
| Current liabilities: | ||
| Accounts payable | $3,513 | $4,398 |
| Accrued liabilities | 13,312 | 8,945 |
| Accrued compensation | 3,962 | 3,147 |
| Lease liabilities | 1,683 | 3,672 |
| Deferred revenue, current portion | 9,038 | 21,639 |
| Total current liabilities | 31,508 | 41,801 |
| Deferred revenue, net of current portion | 33,653 | 28,691 |
| Other long-term liabilities | 775 | 574 |
| Total liabilities | 65,936 | 71,066 |
| Commitments and contingencies | ||
| Stockholders’ equity / Former Parent's deficit: | ||
| Preferred stock, $0.001 par value: 40,000 shares authorized; no shares issued and outstanding | — | — |
| Common stock, $0.001 par value: 400,000 shares authorized; 17,106 shares issued and outstanding as of June 30, 2026, and no shares authorized, issued, or outstanding as of December 31, 2025 | 16 | — |
| Additional paid-in capital | 222,853 | — |
| Accumulated deficit | (8,058) | — |
| Accumulated other comprehensive loss, net | (235) | — |
| Net investment from Former Parent | — | (62,713) |
| Total stockholders’ equity / Former Parent’s deficit | 214,576 | (62,713) |
| Total liabilities and Stockholders’ equity / Former Parent’s deficit | $280,512 | $8,353 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.